Atorvastatin News
High-dose statin before PCI decreases periprocedural MI risk
Loading or reloading with high-dose atorvastatin reduces the risk of periprocedural myocardial infarction (MI) and vascular events in patients undergoing elective percutaneous coronary intervention (PCI), according to data ...
Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline intuberous sclerosis preclinical models
Tuberous sclerosis complex (TSC) is an autosomal dominant tumor suppressor syndrome, characterized by hamartomatous growths in the brain, skin, kidneys, lungs, and heart, which lead to significant morbidity. TSC is caused by ...
Atorvastatin decreases elevated soluble CD40L in subjects at high cardiovascular risk. Atorvastatin on inflammatory markers study: a substudy of ACTFAST
The CD40/CD40 ligand plays a role in the inflammatory and prothrombotic processes in atherosclerosis. We analyzed whether short-term treatment with atorvastatin affects soluble CD40 ligand (sCD40L) plasma levels in subjects at...
Treatment with amlodipine and atorvastatin has additive effect on blood and plaque inflammation in hypertensive patients with carotid atherosclerosis
Since previous studies have reported a beneficial effect of amlodipine and atorvastatin treatment in experimental atherosclerosis, we aimed to investigate the effect of the combination of both drugs on blood and plaque...
Atorvastatin and Celecoxib Synergistic Against Colon Cancer Cells
Atorvastatin and celecoxib synergistically induce cell cycle arrest and apoptosis in colon cancer cells, according to a report in the May 1st International Journal of Cancer.